J9196 Injection gemcitabine hcl (accord)
Also known as: gemcitabine, Accord
Intravenous injection of gemcitabine hydrochloride (Accord brand), a nucleoside analog chemotherapy.
In Plain Language
DNA-inhibiting cancer drug; pancreatic cancer chemotherapy
Clinical Context
Brand-specific formulation of gemcitabine for pancreatic, bladder, and other solid tumors.
RVU Information
CPT J9196 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9196?
CPT J9196 (Injection gemcitabine hcl (accord)) is a J Codes (Drugs) code. Intravenous injection of gemcitabine hydrochloride (Accord brand), a nucleoside analog chemotherapy.
How is J9196 administered?
CPT J9196 is administered by a healthcare provider, typically via injection or infusion. Brand-specific formulation of gemcitabine for pancreatic, bladder, and other solid tumors. It is used by Oncology, Medical Oncology.
When is CPT J9196 used?
Brand-specific formulation of gemcitabine for pancreatic, bladder, and other solid tumors.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.